List of Studies ( Metabolite:PE 18:1_24:5)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003988 | AN006569 | Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active | Cultured cells | Human | Cancer | CNRS | LC-MS |
| ST003125 | AN005123 | Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Fetal liver | Liver | Mouse | Maternal immune system activation | University of Copenhagen | LC-MS |
